Compugen Ltd. Launches Predictive Discovery Platform With 200,000 Novel Genomic Variations

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--Compugen Ltd. (Nasdaq:CGEN) announced today at the 2006 Cold Spring Harbor Meeting on Pharmacogenomics the launch of its GeneVa structural genomic variations platform providing predicted non-SNP (Single Nucleotide Polymorphism), medium and large-scale genetic variations in the human genome.
MORE ON THIS TOPIC